Inventiva S.A. American Depositary Receipt represents Inventiva S.A., a clinical-stage biopharmaceutical company focused on developing oral small-molecule therapies for metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with significant unmet medical need. The company’s current research and development activities center on treatments for metabolic, fibrotic, inflammatory, and rare diseases, with a pipeline that includes programs in liver disease, oncology, fibrosis, and mucopolysaccharidoses. Inventiva S.A. operates as a biotechnology company with international clinical development activity, combining in-house discovery capabilities with late-stage and earlier-stage therapeutic programs. As an American Depositary Receipt, it provides U.S. market access to the company’s ordinary shares and reflects its role as a cross-border biotech issuer with exposure to specialty drug development and clinical research.
Website50 rue de Dijon
Daix, 21121
France
U.S. futures mixed as Vail Resorts fell after a Q4 loss miss despite beating sales estimates; several stocks also declined premarket.
Inventiva (NASDAQ:IVA) said it remains on track to report top-line results from its Phase III NATiV3 trial of lanifibranor in metabolic dysfunction-associated steatohepatitis, or MASH, in the fourth quarter of 2026, after the last patient completed the study’s 72-week visit earlier this month. Chie
On Monday, Inventiva (NASDAQ:IVA) discussed quarterly financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and
Investors talking about IVA also mention
What share of all stock conversation is about IVA?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% -0.01 | 0% +0 | 0% 0 | 0% 0 |
Of the messages about IVA that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% 0 | 100% +24.14 | 60.1% -31.59 | ||
| Bearish | 0% | 0% 0 | 0% -24.14 | 39.9% +31.59 |
Of the messages about IVA that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 0% | 7.41% | 42.61% | 59.42% | ||
| Analysts | 66.67% | 50.62% | 37.5% | 29.65% | ||
| Macro | 0% | 40.74% | 18.75% | 4.15% | ||
| Technical Analysis | 33.33% | 1.23% | 1.14% | 6.16% | ||
| Controversies | 0% | 0% | 0% | 0% | ||
| Earnings | 0% | 0% | 0% | 0.63% |
Of the messages about IVA, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 66.67% | 39.02% | 64.2% | 70.58% | ||
| Newcomers | 33.33% | 60.98% | 35.8% | 29.42% |